Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 11, 2018 - Issue 9
Submit an article Journal homepage
1,901
Views
11
CrossRef citations to date
0
Altmetric
Editorial

The controversies surrounding polypharmacy in old age – where are we?

Kristina JohnellAging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, SwedenCorrespondence[email protected]
View further author information
Pages 825-827 | Received 06 Jul 2018, Accepted 07 Aug 2018, Published online: 20 Aug 2018

References

  • Masnoon N, Sepehr S, Ke, L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230.
  • Fastbom J, Johnell, K. National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging. 2015;32:189–199.
  • Morin L, Laroche, ML, Texier, G, et al. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(862):e1–e9.
  • Morin L, Johnell, K, Laroche, ML, et al. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–298.
  • Fried TR, O’Leary J, Towle V et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–2272.
  • Marengoni A, Angleman, S, Meinow, B, et al. Coexisting chronic conditions in the older population: variation by health indicators. Eur J Intern Med. 2016;31:29–34.
  • Rochon PA, Gurwitz, JH. The prescribing cascade revisited. Lancet. 2017;389:1778–1780.
  • Tinetti ME. The gap between clinical trials and the real world: extrapolating treatment effects from younger to older adults. JAMA Intern Med. 2014;174:397–398.
  • Scott IA, Hilmer, SN, Reeve, E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175:827–834.
  • Finkelstein J, Friedman C, Hripcsak G, Cabrera M. Potential utility of precision medicine for older adults with polypharmacy: a case series study. Pharmgenomics Pers Med. 2016;9:31–45.
  • Reeve E, Wiese MD, Mangoni Aa. Alterations in drug disposition in older adults. Expert Opin Drug Metab Toxicol. 2015;11:491–508.
  • Johnell K. The polypharmacy mouse model: novel findings and new opportunities. J Gerontol A Biol Sci Med Sci. 2016;71:569–570.
  • Huizer-Pajkos A, Kane, AE, Howlett, SE et al. Adverse geriatric outcomes secondary to polypharmacy in a mouse model: the influence of aging. J Gerontol A Biol Sci Med Sci. 2016;71:571–577.
  • Hampton T. Bench to bedside and back again may be key to clinical breakthroughs. JAMA. 2017;318:16–17.
  • Wastesson JW, Fastbom, J, Johnell, K. Expanding the proportion of life with polypharmacy in Sweden: 2006–2013. J Am Med Dir Assoc. 2016;17:957–958.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.